Navigation Links
Statins reduce risks for angioplasty patients

Cholesterol-lowering drugs that help prevent heart disease also appear to cut the risk of a heart attack and other complications after angioplasty.// Angioplasty, an alternative to bypass surgery, allows doctors to open clogged coronary arteries without major surgery by inserting a tiny balloon to the narrowest point and inflating the balloon. But 3 of every 5 patients who go through the procedure will suffer a major setback within 4 years. Some patients suffer heart attacks, others need repeat angioplasty or bypass surgery.

A new study, involving 1,456 patients in 12 countries, has found that cholesterol-lowering drugs could reduce the risk of these complications by 30%, compared with patients taking a placebo. The risk reduced by 40% in patients with more than one clogged artery, and by 45% in patients with diabetes. None of the patients had previously taken the drugs, called statins, and all of them had had their first angioplasty within the previous 8 months.

Statins reduce cholesterol by slowing cholesterol production. Several large studies demonstrated that the drugs prevent heart attacks and heart-disease deaths. Cardiologist Robert Harrington of Duke University said the results are anything but surprising. "It's more evident that statins are good for people with heart disease. we must tell patients undergoing angioplasty that we must start you on a statin."
'"/>




Page: 1

Related medicine news :

1. Statins reduce heart attacks
2. Statins Found To Be Helpful For Patients With Arthritis
3. Long-Term Benefits Of Statins Questioned
4. Statins Not Effective In Treating Calcific Aortic Stenosis
5. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients
6. The Effects of Statins Questioned
7. Statins Taken For Reducing Cholesterol Found To Reduce Death Rate Associated With Heart Attack As Well
8. Study Finds No Link Between Statins And Breast Cancer Risk
9. Statins Reduce Deaths And Strokes After Carotid Surgery
10. Statins reduces cardiovascular risk but no cancer risk.
11. Statins Prescribed To Those Who Are At a Risk Of Developing A Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... NY (PRWEB) , ... May 24, 2017 , ... ... the practice is offering holistic pediatric dentistry options for its patients on Long ... of the patient’s entire physical well being, and is one of the biggest ...
(Date:5/24/2017)... ... 2017 , ... Dymedix® Diagnostics, Inc., the leading ... had completed the first phase of building a global distribution network. To date, ... (ROW) authorized dealers specializing in polysomnography accessories. The company plans to expand ...
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, ... steady since 2009, according to a Workers Compensation Research Institute (WCRI) study, a ... the North Carolina System: CompScope™ Benchmarks, 17th Edition looks at indemnity and ...
(Date:5/23/2017)... ... May 23, 2017 , ... The Gallery of ... Sadati, is pleased to announce a new treatment option called Vivace Microneedling. This ... face, neck, and body through a virtually pain-free, non-surgical treatment. Vivace Microneedling combines ...
(Date:5/23/2017)... ... May 23, 2017 , ... New patients from Charleston, SC, ... experienced dentist practicing in Mt. Pleasant, SC, with or without a referral. A full ... patients with missing teeth in Charleston, SC. Those who suffer from gum ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)...  The Corporate Whistleblower Center says, "We are ... clinics to call us anytime at 866-714-6466 if they ... in a substantial scheme to overbill Medicare. We ... employee of a medical equipment company if their ... medical practice groups with extra generous incentives to use, ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
Breaking Medicine Technology: